Other

Operating And Finance Lease, Liability, Noncurrent

Moderna Operating And Finance Lease, Liability, Noncurrent decreased by 2.2% to $658.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.3%, from $702.00M to $658.00M. Over 5 years (FY 2020 to FY 2025), Operating And Finance Lease, Liability, Noncurrent shows an upward trend with a 26.6% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2019
Last reportedQ1 2026May 1, 2026
Metric ID: other_operating_and_finance_lease_liability_noncurrent_10f520

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$433.00M$343.00M$705.00M$741.00M$728.00M$1.00B$1.00B$927.00M$947.00M$1.27B$1.22B$1.21B$1.24B$1.30B$710.00M$702.00M$698.00M$686.00M$673.00M$658.00M
QoQ Change-20.8%+105.5%+5.1%-1.8%+37.5%+0.3%-7.7%+2.2%+34.3%-4.2%-0.5%+2.6%+4.8%-45.6%-1.1%-0.6%-1.7%-1.9%-2.2%
YoY Change+68.1%+191.8%+42.4%+25.1%+30.1%+27.1%+21.3%+30.7%+31.4%+2.5%-41.7%-42.1%-43.9%-47.4%-5.2%-6.3%
Range$343.00M$1.30B
CAGR+9.2%
Avg YoY Growth+17.8%
Median YoY Growth+23.2%
Current Streak6 quarters decline

Frequently Asked Questions

What is Moderna's operating and finance lease, liability, noncurrent?
Moderna (MRNA) reported operating and finance lease, liability, noncurrent of $658.00M in Q1 2026.
How has Moderna's operating and finance lease, liability, noncurrent changed year-over-year?
Moderna's operating and finance lease, liability, noncurrent decreased by 6.3% year-over-year, from $702.00M to $658.00M.
What is the long-term trend for Moderna's operating and finance lease, liability, noncurrent?
Over 5 years (2020 to 2025), Moderna's operating and finance lease, liability, noncurrent has grown at a 26.6% compound annual growth rate (CAGR), from $207.00M to $673.00M.